Urine| Hair Follicle | Oral Fluid | Blood | ETG
The use of hair testing is increasingly recognized as a significant method for identifying drug and alcohol consumption. Hair captures a historical record of substances and alcohol, embedding biomarkers within the strands as they grow. When clipped close to the scalp, hair reveals a detection period of up to approximately three months for these substances. It is easy to gather, somewhat resistant to tampering, and convenient to transport.
Harvesting a 1.5-inch segment of roughly 200 strands of hair (akin to the girth of a #2 pencil) directly from above the scalp will generate 100mg of hair, which is the prime quantity for initial testing and verification. For EtG, any additional tests, and examinations exceeding ten panels, a collection of 150mg is advisable. Utilizing a jeweler’s scale to gauge the sample’s mass is suggested. If scalp hair is inaccessible, an equivalent volume of body hair is an acceptable alternative. By head hair, we mean solely the scalp hair. Body hair encompasses all other varieties of hair (such as facial or axillary).
Process Overview
The pivotal steps in processing a drug test outcome in a lab encompass Accessioning, Screening, Extraction, and Confirmation.
Accessioning signifies the commencement of processing a sample into the lab’s system. This stage involves ensuring the sample’s proper sealing and dispatch, issuing a random LAN (Laboratory Accessioning Number), and finalizing any data input not included by an electronic custody chain.
Screening provides an initial, swift examination for substance abuse. This method offers an economical means to exclude drug usage in most samples, though any positive findings must be verified for judicial acceptability. Samples deemed presumptively positive in Screening necessitate an additional confirmation.
Should a sample appear presumptively positive during Screening, additional hair is extracted from the original sample and readied for Extraction. At this juncture, substances are drawn from hair at notably lower densities than other approaches (like urine or oral fluid), highlighting why hair drug screening is amongst the most complex to conduct.
GC/MS, GC/MS/MS, or LC/MS/MS methods carry out Confirmation of a positive screening outcome. Any samples found presumptively positive undergo pre-confirmation washing as needed. The entire lab procedure from Accessioning to Confirmation is overseen as per CAP (College of American Pathologists) Hair designation and ISO / IEC 17025 accreditation.
Advantages of hair drug testing:
Limitations:
Note: Though frequently termed "hair follicle tests", these tests evaluate the hair shaft rather than the follicle beneath the scalp.
Why Hair Follicle Testing Beats Urine Testing in Waverly, FL Hair follicle testing is a standout when compared to traditional urine tests.
Extended Detection Window in Waverly, FL A hallmark of hair follicle testing is its ability to identify drug use over an extended timeframe, reaching up to 90 days.
Tamper-Resistant Testing Method in Waverly, FL The robustness of hair follicle testing lies in its resistance to tampering.
Convenient Nationwide Testing Locations and Local Locations in Waverly, FL Our widespread network, including locations in Waverly, FL, ensures simplicity and accessibility for drug-testing needs.
Simple, Confidential Process in Waverly, FL The hair follicle testing procedure is designed for ease and privacy.
Affordable Pricing and Fast Turnaround in Waverly, FL With competitive pricing and swift results, clients in Waverly receive outstanding value.
Fast, Accurate, and Reliable Results in Waverly, FL Hair follicle tests are known for their precision and expedited processing. This method offers superior accuracy, detecting substance use with remarkable reliability. In Waverly, FL, individuals can trust in the quick turnaround and dependable outcomes, making it a preferred choice for those needing consistent test results.
Compliance and Peace of Mind for Employers in Waverly, FL Utilizing hair follicle testing aids employers in maintaining adherence to drug-free workplace mandates.
